Drugdrug interactions and their potential impact on toxicity levels in patients with b-cell malignancy

Ral Crdoba, MD, PhD, of University Hospital Fundacin Jimnez Daz, Madrid, Spain, discusses results from a drugdrug interaction study (NCT02381080) of ibrutinib with moderate and strong cytochrome... Author: VJHemOnc Added: 01/05/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts